178 related articles for article (PubMed ID: 24013182)
1. External validation of the RENAL nephrometry score nomogram for predicting high-grade renal cell carcinoma in solid, enhancing, and small renal masses.
Koo KC; Yoo H; Shin TY; Kim J; Choi YD; Rha KH; Ham WS
World J Urol; 2014 Feb; 32(1):249-55. PubMed ID: 24013182
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of anatomic and morphologic nomogram to predict malignant and high-grade disease in a cohort of patients with small renal masses.
Bagrodia A; Harrow B; Liu ZW; Olweny EO; Faddegon S; Yin G; Tan YK; Han WK; Lotan Y; Margulis V; Cadeddu JA
Urol Oncol; 2014 Jan; 32(1):37.e17-23. PubMed ID: 23628308
[TBL] [Abstract][Full Text] [Related]
3. Anatomic features of enhancing renal masses predict malignant and high-grade pathology: a preoperative nomogram using the RENAL Nephrometry score.
Kutikov A; Smaldone MC; Egleston BL; Manley BJ; Canter DJ; Simhan J; Boorjian SA; Viterbo R; Chen DY; Greenberg RE; Uzzo RG
Eur Urol; 2011 Aug; 60(2):241-8. PubMed ID: 21458155
[TBL] [Abstract][Full Text] [Related]
4. External validation of a nomogram including the computed tomography imaging score to predict indolent renal masses.
Chen X; Wan B; Yang D; Zhao H; Tan W
Int Urol Nephrol; 2017 Jul; 49(7):1119-1126. PubMed ID: 28417341
[TBL] [Abstract][Full Text] [Related]
5. External validation of a nomogram using RENAL nephrometry score to predict high grade renal cell carcinoma.
Wang HK; Zhu Y; Yao XD; Zhang SL; Dai B; Zhang HL; Shen YJ; Wang CF; Ye DW
J Urol; 2012 May; 187(5):1555-60. PubMed ID: 22425078
[TBL] [Abstract][Full Text] [Related]
6. The R.E.N.A.L. nephrometric nomogram cannot accurately predict malignancy or aggressiveness of small renal masses amenable to partial nephrectomy.
Antonelli A; Furlan M; Sandri M; Minervini A; Cindolo L; Parma P; Zaramella S; Porreca A; Vittori G; Samuelli A; Dente D; Berardinelli F; Raspollini MR; Serni S; Carini M; Terrone C; Schips L; Simeone C
Clin Genitourin Cancer; 2014 Oct; 12(5):366-72. PubMed ID: 24637340
[TBL] [Abstract][Full Text] [Related]
7. A preoperative prognostic nomogram for solid enhancing renal tumors 7 cm or less amenable to partial nephrectomy.
Lane BR; Babineau D; Kattan MW; Novick AC; Gill IS; Zhou M; Weight CJ; Campbell SC
J Urol; 2007 Aug; 178(2):429-34. PubMed ID: 17561141
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Percutaneous Renal Mass Biopsy and R.E.N.A.L. Nephrometry Score Nomograms for Determining Benign Vs Malignant Disease and Low-risk Vs High-risk Renal Tumors.
Osawa T; Hafez KS; Miller DC; Montgomery JS; Morgan TM; Palapattu GS; Weizer AZ; Caoili EM; Ellis JH; Kunju LP; Wolf JS
Urology; 2016 Oct; 96():87-92. PubMed ID: 27262393
[TBL] [Abstract][Full Text] [Related]
9. CT features based preoperative predictors of aggressive pathology for clinical T1 solid renal cell carcinoma and the development of nomogram model.
Wang K; Dong L; Li S; Liu Y; Niu Y; Li G
BMC Cancer; 2024 Jan; 24(1):148. PubMed ID: 38291357
[TBL] [Abstract][Full Text] [Related]
10. Predictive Nomogram for Recurrence following Surgery for Nonmetastatic Renal Cell Cancer with Tumor Thrombus.
Abel EJ; Masterson TA; Karam JA; Master VA; Margulis V; Hutchinson R; Lorentz CA; Bloom E; Bauman TM; Wood CG; Blute ML
J Urol; 2017 Oct; 198(4):810-816. PubMed ID: 28411071
[TBL] [Abstract][Full Text] [Related]
11. Development of a simple nomogram to estimate risk for intraoperative complications before partial nephrectomy based on the Mayo Adhesive Probability score combined with the RENAL nephrometry score.
Tan X; Jin D; Hu J; Zhang W; Zhou Y; Li Y; Zhang Y; Wu J
Investig Clin Urol; 2021 Jul; 62(4):455-461. PubMed ID: 34190437
[TBL] [Abstract][Full Text] [Related]
12. Predictive Nomogram for Midterm to Long-Term Prognosis in Patients with Papillary Renal Cell Carcinoma Based on Data from the Surveillance, Epidemiology, and End Results (SEER) Program.
Wang H; Chen X; Zhao J; Kang M; Dong R; Wang K; Qu Y
Med Sci Monit; 2020 Jun; 26():e921859. PubMed ID: 32570266
[TBL] [Abstract][Full Text] [Related]
13. Validation of a Postoperative Nomogram Predicting Recurrence in Patients with Conventional Clear Cell Renal Cell Carcinoma.
Lee BH; Feifer A; Feuerstein MA; Benfante NE; Kou L; Yu C; Kattan MW; Russo P
Eur Urol Focus; 2018 Jan; 4(1):100-105. PubMed ID: 28753780
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic performance of prospectively assigned clear cell Likelihood scores (ccLS) in small renal masses at multiparametric magnetic resonance imaging.
Johnson BA; Kim S; Steinberg RL; de Leon AD; Pedrosa I; Cadeddu JA
Urol Oncol; 2019 Dec; 37(12):941-946. PubMed ID: 31540830
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and prognostic value of FBXO11 expression in patients with clear cell renal cell carcinoma.
Fan B; Wang W; Zhang X; Sun M; Wang X; Chen Z; Liu W; Wang Q; Yu N; Li X
BMC Cancer; 2019 Jun; 19(1):534. PubMed ID: 31159774
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a nomogram to predict overall survival for patients with metastatic renal cell carcinoma.
Zheng W; Zhu W; Yu S; Li K; Ding Y; Wu Q; Tang Q; Zhao Q; Lu C; Guo C
BMC Cancer; 2020 Nov; 20(1):1066. PubMed ID: 33148204
[TBL] [Abstract][Full Text] [Related]
17. Low predictive accuracy of the Kattan postoperative nomogram for renal cell carcinoma recurrence in a population of French patients.
Hupertan V; Roupret M; Poisson JF; Chretien Y; Dufour B; Thiounn N; Mejean A
Cancer; 2006 Dec; 107(11):2604-8. PubMed ID: 17075871
[TBL] [Abstract][Full Text] [Related]
18. Assessing the anatomical characteristics of renal masses has a limited effect on the prediction of pathological outcomes in solid, enhancing, small renal masses: results using the PADUA classification system.
Shin TY; Kim J; Koo KC; Lim SK; Kim DW; Kang MW; Rha KH; Choi YD; Ham WS
BJU Int; 2014 May; 113(5):754-61. PubMed ID: 24053790
[TBL] [Abstract][Full Text] [Related]
19. Preoperative prognostic nomogram (probability table) for renal cell carcinoma based on TNM classification.
Kanao K; Mizuno R; Kikuchi E; Miyajima A; Nakagawa K; Ohigashi T; Nakashima J; Oya M
J Urol; 2009 Feb; 181(2):480-5; discussion 485. PubMed ID: 19100568
[TBL] [Abstract][Full Text] [Related]
20. p53-expression in patients with renal cell carcinoma correlates with a higher probability of disease progression and increased cancer-specific mortality after surgery but does not enhance the predictive accuracy of robust outcome models.
Morshaeuser L; May M; Burger M; Otto W; Hutterer GC; Pichler M; Klatte T; Wild P; Buser L; Brookman-May S
Urol Oncol; 2018 Mar; 36(3):94.e15-94.e21. PubMed ID: 29221641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
